Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.85
+0.03 (0.31%)
Apr 29, 2026, 2:08 PM EDT - Market open
CRBP Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 175 | 151 | 144 | 27 | 14 | 77 | |
| Market Cap Growth | 136.41% | 4.94% | 437.89% | 93.01% | -82.05% | -26.60% | |
| Enterprise Value | 16 | 49 | -12 | 21 | -27 | -4 | |
| Last Close Price | 9.82 | 8.14 | 11.80 | 6.04 | 3.32 | 18.47 | |
| PS Ratio | - | - | - | - | - | 87.45 | |
| PB Ratio | 1.17 | 1.02 | 1.01 | -3.87 | 0.42 | 1.12 | |
| P/TBV Ratio | 1.20 | 1.02 | 1.01 | - | 0.42 | 1.12 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | -3.02 | 0.76 | 0.39 | |
| Net Debt / Equity Ratio | -1.10 | -1.10 | -1.02 | 0.00 | -1.03 | -1.03 | |
| Net Debt / EBITDA Ratio | 1.90 | 1.90 | 3.03 | 0 | 1.00 | 1.29 | |
| Net Debt / FCF Ratio | 2.51 | 2.51 | 3.49 | 0.00 | 0.91 | 1.47 | |
| Asset Turnover | - | - | - | - | - | 0.01 | |
| Quick Ratio | 7.96 | 7.96 | 12.61 | 0.66 | 4.68 | 5.74 | |
| Current Ratio | 8.07 | 8.07 | 12.94 | 0.74 | 4.76 | 5.89 | |
| Return on Equity (ROE) | -54.18% | -54.18% | -59.34% | -341.99% | -82.95% | -79.80% | |
| Return on Assets (ROA) | -32.91% | -32.91% | -33.07% | -59.57% | -25.02% | -33.32% | |
| Return on Capital Employed (ROCE) | -57.80% | -57.80% | -33.80% | 1244.60% | -64.90% | -61.70% | |
| Earnings Yield | -44.28% | -52.07% | -27.98% | -166.94% | -305.90% | -59.19% | |
| FCF Yield | -36.36% | -42.76% | -29.08% | -135.11% | -271.30% | -62.56% | |
| Buyback Yield / Dilution | -22.00% | -22.00% | -152.23% | -3.76% | -1.85% | -57.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.